Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Eli Lilly & Co (LLY)  
$914.37 8.99 (0.99%) as of 4:30 Mon 7/1


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 956,580,000
Market Cap: 874.67(B)
Last Volume: 2,545,641 Avg Vol: 3,268,697
52 Week Range: $434.7 - $909.04
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 500

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  720
Guru Rank Value     : 1.4
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s products include: diabetes products, oncology products, immunology products, neuroscience products, and other therapies. Co.'s diabetes products include: Baqsimi®, Basaglar®, Humalog®, Humulin®, Jardiance®, Lyumjev®, Trajenta®, and Trulicity®. Co.'s oncology products include: Alimta®, Cyramza®, Erbitux®, Retevmo®, Tyvyt®, and Verzenio®. Co.'s immunology products include: Olumiant® and Taltz®. Co.'s neuroscience products include: Cymbalta®, Emgality®, Reyvow®, and Zyprexa®. Co.'s other therapies include: Bamlanivimab, Cialis®, and Forteo®.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 656
Total Buy Value $0 $0 $0 $199,549
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 1,520,577 2,391,327 3,771,329 6,318,238
Total Sell Value $1,284,658,855 $1,892,909,435 $2,147,483,647 $2,147,483,647
Total People Sold 3 3 4 6
Total Sell Transactions 18 31 50 93
End Date 2024-03-31 2023-12-29 2023-06-30 2022-06-30

   
Records found: 1436
  Page 56 of 58  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Lilly Endowment Inc 10% Owner   –       –       •   2014-10-31 4 S $66.37 $12,616,315 D/D (190,000) 132,155,804     -
   Alvarez Ralph Director   –       •      –    2014-10-31 4 A $63.10 $8,582 D/D 136 24,000     -
   Lilly Endowment Inc 10% Owner   –       –       •   2014-10-30 4 S $66.57 $11,651,563 D/D (175,000) 132,345,804     -
   Lechleiter John C Chairman, President and CEO   •       •      –    2014-10-29 4 D $64.83 $7,656,229 D/D (118,097) 530,579     -
   Lechleiter John C Chairman, President and CEO   •       •      –    2014-10-29 4 OE $55.65 $7,112,682 D/D 127,811 648,676     -
   Crowe Maria A President, Mfg. Operations   •       –      –    2014-10-27 4 D $66.05 $370,673 D/D (5,612) 37,045     -
   Crowe Maria A President, Mfg. Operations   •       –      –    2014-10-27 4 OE $55.65 $355,659 D/D 6,391 42,657     -
   Crowe Maria A President, Mfg. Operations   •       –      –    2014-10-24 4 S $65.77 $180,868 D/D (2,750) 36,266     -
   Lilly Endowment Inc 10% Owner   –       –       •   2014-10-06 4 S $65.63 $13,782,300 D/D (210,000) 132,520,804     -
   Crowe Maria A President, Mfg. Operations   •       –      –    2014-10-03 4 D $64.83 $236,370 D/D (3,646) 39,016     -
   Crowe Maria A President, Mfg. Operations   •       –      –    2014-10-03 4 OE $0.00 $0 D/D 9,175 42,662     -
   Zulueta Alfonso G SVP& Pres., Emerging Markets   •       –      –    2014-10-01 4 D $64.85 $284,302 D/D (4,384) 39,112     -
   Zulueta Alfonso G SVP& Pres., Emerging Markets   •       –      –    2014-10-01 4 OE $0.00 $0 D/D 9,333 43,496     -
   Conterno Enrique A Sr. VP & Pres., Lilly Diabetes   •       –      –    2014-10-01 4 AS $64.86 $324,300 D/D (5,000) 77,736     -
   Lilly Endowment Inc 10% Owner   –       –       •   2014-09-30 4 S $65.07 $13,014,000 D/D (200,000) 132,730,804     -
   Alvarez Ralph Director   –       •      –    2014-09-30 4 A $65.19 $8,605 D/D 132 23,864     -
   Rice Derica W EVP-Global Services and CFO   •       –      –    2014-09-15 5 GA $0.00 $0 I/I 26,749 278,263     -
   Rice Derica W EVP-Global Services and CFO   •       –      –    2014-09-15 5 GD $0.00 $0 D/D 26,749 0     -
   Lechleiter John C Chairman, President and CEO   •       •      –    2014-09-12 4 GD $0.00 $0 D/D 12,631 520,865     -
   Barnes Melissa S Chief Eth/Cmpl Ofcr & SVP, ERM   •       –      –    2014-09-12 4 D $65.18 $169,012 D/D (2,593) 3,644     -
   Barnes Melissa S Chief Eth/Cmpl Ofcr & SVP, ERM   •       –      –    2014-09-12 4 OE $55.65 $164,529 D/D 2,941 5,084     -
   Lilly Endowment Inc 10% Owner   –       –       •   2014-09-10 4 S $64.77 $13,601,700 D/D (210,000) 132,930,804     -
   Ricks David A SVP and Pres, Lilly Bio-Meds   •       –      –    2014-09-08 4 D $64.72 $87,566 D/D (1,353) 34,240     -
   Ricks David A SVP and Pres, Lilly Bio-Meds   •       –      –    2014-09-08 4 OE $55.65 $83,976 D/D 1,509 35,593     -
   Rice Derica W EVP-Global Services and CFO   •       –      –    2014-09-04 4 D $64.15 $1,368,191 D/D (21,328) 26,749     -
  1436 Records found
  Previous  50  51  52  53  54  55  56  57  58   
  Page 56 of 58
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us